Analyst Ratings for Salarius Pharmaceuticals (SLRX)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
9/23/2021 | Ladenburg Thalmann | Ahu Demir | New Coverage | Buy (N/A) |
5.00 (N/A) |
1.05 (0.51) |
-51.43% | Details |
8/25/2021 | H.C. Wainwright | Michael King | New Coverage | Buy (N/A) |
5.00 (N/A) |
0.94 (0.51) |
-45.74% | Details |